OncoPharm cover image

Adjuvant Pembrolizumab (NSCLC), Elacestrant, & Pirtobrutinib

OncoPharm

00:00

Outro

John closes the episode with social links, thanks listeners, and signs off with a reminder that doses matter.

Play episode from 17:25
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app